Clomipramine treatment of delusional disorder, somatic type

Int Clin Psychopharmacol. 1999 May;14(3):181-3.

Abstract

Four patients of delusional disorder, somatic type, were treated with clomipramine 60-120 mg/day. All patients showed marked clinical improvement after 27-57 days of clomipramine treatment. In one case, previous treatments by various antipsychotic drugs including pimozide had been unsuccessful. This report suggests that clomipramine is effective at least for some patients with delusional disorder, somatic type, including pimozide-resistant cases. It is also suggested that there is some association between delusional disorder, somatic type, and serotonergic dysfunction.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Antipsychotic Agents / therapeutic use
  • Clomipramine / therapeutic use*
  • Female
  • Humans
  • Hypochondriasis / drug therapy
  • Hypochondriasis / psychology
  • Male
  • Middle Aged
  • Pimozide / therapeutic use
  • Psychophysiologic Disorders / drug therapy*
  • Psychophysiologic Disorders / psychology
  • Schizophrenia, Paranoid / drug therapy*
  • Schizophrenia, Paranoid / psychology

Substances

  • Antidepressive Agents, Tricyclic
  • Antipsychotic Agents
  • Pimozide
  • Clomipramine